Biofusion Therapeutics Limited - Company Profile

It is a life sciences public limited company based in Bengaluru, Karnataka, India, established in 2021.
2021 Bengaluru, Karnataka, India Amalgamated
Last Updated:
Access Report
About Biofusion Therapeutics Limited

Biofusion Therapeutics Limited, a amalgamated public limited company, was established on 18 March 2021 in Bengaluru, Karnataka, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U73100KA2021PLC145487. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.

Employing 3 professional, Its leadership includes Kiran Mazumdar Shaw (Director), Siddharth Mittal (Director), Karaikal Narayanaswamy Murali Krishnan (Director). Past directors included John Mccallum Marshall Shaw, Karaikal Narayanaswamy Murali Krishnan. It holds no open charges and ₹42.71 Cr settled loans. Its latest AGM occurred on 11 August 2023, with the balance sheet filed on 31 March 2023. It is based at 4Th Floor, Pod2, Brc Building, Biocon Special Economic Zone, Bommasandra Industrial Ar, Ea, Bengaluru, Karnataka, 560099.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100KA2021PLC145487

  • Registration Number

    145487

  • Incorporation Date

    18 March 2021

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 5 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 42.71 Cr
  • Revenue Growth **** 40.67%
  • Profit Growth **** 2670.46%
  • Ebitda **** -71.61%
  • Net Worth 2642.46%
  • Total Assets -64.51%
Company report

Biofusion Therapeutics Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Biofusion Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Biofusion Therapeutics Limited?
Current Directors
Name Designation Appointment Date Status
Kiran Mazumdar Shaw Director 18 Mar 2021 Current
Siddharth Mittal Director 18 Mar 2021 Current
Karaikal Narayanaswamy Murali Krishnan Director 27 Jul 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Jul 2022 Past
Pramod Abcsdd Additional Director 10 Aug 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biofusion Therapeutics.

Biofusion Therapeutics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.67% increase. The company also saw a substantial improvement in profitability, with a 2670.46% increase in profit. The company's net worth Soared by an impressive increase of 2642.46%.

Biofusion Therapeutics revenue growth over time
Biofusion Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 40.67%
*******
*******
*******
*******
Revenue from Operations
*******
 -52.27%
*******
*******
*******
*******
Total Assets
*******
 -64.51%
*******
*******
*******
*******
Profit or Loss
*******
 2670.46%
*******
*******
*******
*******
Net Worth
*******
 2642.46%
*******
*******
*******
*******
EBITDA
*******
 -71.61%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biofusion Therapeutics?

In 2023, Biofusion Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹427,141,825.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 42.71 Cr
Latest Charge Details
Date Lender Amount Status
21 Apr 2022 Citi Bank N.A. ₹42.71 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Biofusion Therapeutics?

Biofusion Therapeutics has a workforce of 3 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biofusion Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofusion Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biofusion Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Biofusion Therapeutics Limited last Annual general meeting of members was held on 11 Aug 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Biofusion Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was documented.

  • Charges

    A charge registered on 21 Apr 2022 via Charge ID 100581935 with Citi Bank N.A. was fully satisfied on 26 Dec 2022. was recorded as a recent event.

  • Director Appointment

    The activity Karaikal Narayanaswamy Murali Krishnan was appointed as a Director was appointed as a Director on 27 Jul 2022 & has been associated with this company since 3 years 8 months . was completed.

  • Charges

    A charge with Citi Bank N.A. amounted to Rs. 427.14 M with Charge ID 100581935 was registered on 21 Apr 2022. was recorded as a recent event.

  • Director Appointment

    Progress on Kiran Mazumdar Shaw was appointed as a Director was appointed as a Director on 18 Mar 2021 & has been associated with this company since 5 years 1 month . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biofusion Therapeutics Limited?

The CIN of Biofusion Therapeutics Limited is U73100KA2021PLC145487.

Where is Biofusion Therapeutics Limited headquartered?

Biofusion Therapeutics Limited is headquartered at 4Th Floor, Pod2, Brc Building, Biocon Special Economic Zone, Bommasandra Industrial Ar, Ea, Bengaluru, Karnataka, 560099.

When was Biofusion Therapeutics Limited incorporated?

Biofusion Therapeutics Limited was incorporated on 18 March 2021.

Who are the current directors of Biofusion Therapeutics Limited?

The current directors of Biofusion Therapeutics Limited are

What is the primary industry of Biofusion Therapeutics Limited?

The primary industry of Biofusion Therapeutics Limited is Manufacturing.

Is Biofusion Therapeutics Limited a listed company?

Biofusion Therapeutics Limited is unlisted.

What is the capital structure of Biofusion Therapeutics Limited?

The authorized capital of Biofusion Therapeutics Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available